Viewing nowCombinationTradian Tablets 10/5 mg (Empagliflozin, Linagliptin)
Empagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Dongkoo Bio Pharmaceutical Co., Ltd.

MFDS item code 202302840 · Approved 2023.09.27
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood sugar control when taken by patients with type 2 diabetes in conjunction with dietary and exercise regimens. The combination of Empagliflozin and Linagliptin effectively lowers blood sugar and has a positive impact on diabetes management. Therefore, this medication is used for the treatment of type 2 diabetes.
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the regularly scheduled time. Do not take a double dose in one day. This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication contains two active ingredients, Empagliflozin and Linagliptin, and is primarily used for the treatment of type 2 diabetes. Empagliflozin works by preventing the reabsorption of sugar in the kidneys, promoting the excretion of sugar in urine, thus lowering blood sugar levels, while Linagliptin enhances insulin secretion, aiding in blood sugar control. However, this medication should not be used by patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Caution should be exercised when administering to patients with impaired renal function, and it is important to regularly monitor kidney function before and after administration. The use of this medication is not recommended for patients with severe heart failure, thus special attention is required. Moreover, rare side effects such as acute pancreatitis or blistering dermatosis may occur while taking this medication, and if symptoms such as abdominal pain or skin abnormalities arise, immediate consultation with healthcare professionals is necessary. The most common side effect of this medication is urinary tract infection, which may occur more frequently in women. The risk of hypoglycemia is low when this medication is used alone, but may increase when used with other hypoglycemic agents such as insulin or sulfonylureas, necessitating careful monitoring of blood sugar levels. Low blood pressure may occur due to fluid loss, thus patients undergoing treatment for hypertension, those with hypotension, and elderly patients over 75 years old should exercise particular caution. This medication may increase the risk of genital fungal infections, so appropriate treatment is needed if related symptoms develop. The use of this medication during pregnancy is not recommended, and it is advisable to discontinue breastfeeding while on this medication. Safety and efficacy in children and adolescents under 18 years of age have not been established, so its use is discouraged in these populations. Although tolerability is relatively good in the event of overdose, patients should immediately inform healthcare professionals if symptoms occur and receive necessary treatment. Lastly, this medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and should be kept at room temperature between 1 degree and 30 degrees Celsius. Storing the medication in this manner helps maintain its efficacy over time.
Pale yellow triangular film-coated tablets
10 tablets/Blister [(10 tablets/Blister x1)], 30 tablets/Blister [(10 tablets/Blister x3)], 30 tablets/Bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Dongkoo Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Empagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.